Top Markets
Coin of the day
AiXin Life International, Inc. AiXin Life International, Inc.

AiXin Life International, Inc.

AIXN
Rangering i aksjer #33968
AiXin Life International, Inc. develops, manufactures, markets, and sells... AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.
Aksjekurs
$0.26
Sist synkronisert: 2026-08-13
Markedsverdi
$6.50M
Endring (1 dag)
0.00%
Endring (1 år)
152.43%
Land
CN
Handel AiXin Life International, Inc. (AIXN)

Kategori

Inntekter for AiXin Life International, Inc. (AIXN)
Inntekter i 2026 TTM: 0
Ifølge AiXin Life International, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for AiXin Life International, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$6.46B -
US
- -
US
$2.17B -
US
- -
US
$358.16M -
AU